Synlait outlines testing, supply chain pressures after a2 Milk China update

Synlait Milk Ltd. ( (AU:SM1) ) has issued an announcement.

Synlait Milk Limited has clarified its position following an announcement by key customer The a2 Milk Company about trading, supply chain and outlook issues in its China-focused infant milk formula business. Synlait said it has introduced enhanced testing across all infant formula products, which has lengthened product release times and increased working capital needs, while it works through related supply chain impacts in coordination with The a2 Milk Company.

The company reported that it is rebuilding customer inventories after earlier manufacturing challenges, with production now back at targeted levels. Synlait reiterated that it will not provide financial guidance for FY26 and highlighted that The a2 Milk Company’s update underlines the wider risks facing the infant formula sector, including delayed product clearance, complex global logistics, regulatory changes, and a challenging geopolitical and trading environment that are affecting its operations and cash flow visibility.

More about Synlait Milk Ltd.

Synlait Milk Limited is a New Zealand-based dairy processing company that produces value-added milk products, including infant milk formula, for global markets. The company supplies key customers such as The a2 Milk Company and has significant exposure to the Chinese infant formula market, where regulatory and demand dynamics play a major role in its performance.

For detailed information about SM1 stock, go to TipRanks’ Stock Analysis page.